Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. 1995

M Detmar, and K T Yeo, and J A Nagy, and L Van de Water, and L F Brown, and B Berse, and B M Elicker, and S Ledbetter, and H F Dvorak
Department of Pathology, Beth Israel Hospital, Harvard Medical School, Boston, MA 02215, USA.

Expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) is markedly increased in the epidermis of lesional psoriatic skin and in healing skin wounds. In this study, we characterized the effects of several cytokines and growth factors on the expression and secretion of VPF/VEGF mRNA and protein by cultured human epidermal keratinocytes, as well as the effect of VPF/VEGF on the growth of cultured human dermal microvascular endothelial cells. Transforming growth factor-alpha, epidermal growth factor, and phorbol myristate acetate markedly stimulated VPF/VEGF mRNA expression by cultured keratinocytes; as in psoriatic skin, the three most common VPF/VEGF isoforms (encoding proteins of 121, 165, and 189 amino acids) were upregulated to an equal extent. Transforming growth factor (TGF)-alpha, epidermal growth factor, and phorbol myristate acetate also enhanced the secretion of VPF/VEGF by keratinocytes; in contrast, a number of other cytokines including interleukin (IL)-1, IL-6, IL-8, tumor necrosis factor-alpha, interferon-gamma, and transforming growth factor-beta did not induce VPF/VEGF secretion. The VPF/VEGF secreted by keratinocytes was biologically active in that, like recombinant human VPF/VEGF, it potently stimulated dermal endothelial cell proliferation. Scatchard analysis revealed two high-affinity VPF/VEGF binding sites on dermal endothelial cells with dissociation constants of 51 pM and 2.9 pM. These results suggest that the avascular epidermis has the capacity to regulate dermal angiogenesis and microvascular permeability by a paracrine mechanism involving the secretion of VPF/VEGF. Similar mechanisms may be anticipated in a variety of inflammatory and neoplastic skin diseases characterized by microvascular hyperpermeability, edema, and angiogenesis.

UI MeSH Term Description Entries
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D015603 Keratinocytes Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell. Keratinocyte

Related Publications

M Detmar, and K T Yeo, and J A Nagy, and L Van de Water, and L F Brown, and B Berse, and B M Elicker, and S Ledbetter, and H F Dvorak
June 1999, Microcirculation (New York, N.Y. : 1994),
M Detmar, and K T Yeo, and J A Nagy, and L Van de Water, and L F Brown, and B Berse, and B M Elicker, and S Ledbetter, and H F Dvorak
May 1997, Oncogene,
M Detmar, and K T Yeo, and J A Nagy, and L Van de Water, and L F Brown, and B Berse, and B M Elicker, and S Ledbetter, and H F Dvorak
May 1995, The American journal of pathology,
M Detmar, and K T Yeo, and J A Nagy, and L Van de Water, and L F Brown, and B Berse, and B M Elicker, and S Ledbetter, and H F Dvorak
January 1996, The Journal of investigative dermatology,
M Detmar, and K T Yeo, and J A Nagy, and L Van de Water, and L F Brown, and B Berse, and B M Elicker, and S Ledbetter, and H F Dvorak
January 2011, PloS one,
M Detmar, and K T Yeo, and J A Nagy, and L Van de Water, and L F Brown, and B Berse, and B M Elicker, and S Ledbetter, and H F Dvorak
April 1987, Biochemical and biophysical research communications,
M Detmar, and K T Yeo, and J A Nagy, and L Van de Water, and L F Brown, and B Berse, and B M Elicker, and S Ledbetter, and H F Dvorak
May 1997, Journal of immunology (Baltimore, Md. : 1950),
M Detmar, and K T Yeo, and J A Nagy, and L Van de Water, and L F Brown, and B Berse, and B M Elicker, and S Ledbetter, and H F Dvorak
December 1989, Science (New York, N.Y.),
M Detmar, and K T Yeo, and J A Nagy, and L Van de Water, and L F Brown, and B Berse, and B M Elicker, and S Ledbetter, and H F Dvorak
June 1995, Journal of cell science,
M Detmar, and K T Yeo, and J A Nagy, and L Van de Water, and L F Brown, and B Berse, and B M Elicker, and S Ledbetter, and H F Dvorak
April 2001, The Journal of investigative dermatology,
Copied contents to your clipboard!